Uptrend Under Pressure 93
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 93/100 · 7 distribution days (SPY) Sep 11 Full briefing →
View
Simple research view

CRL · Charles River Laboratories International, Inc.

$273.00 -1.92% Sep 10 close
Detected setup Momentum Flag · Setup Score 65/100

Stand aside — setup invalidated

Setup score 65, but price closes below stop $291.52 — stand aside until the condition resets.

Ask about CRL

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$CRL

Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. is a large-cap Miscellaneous Commercial Services company in the Commercial Services sector with a market cap of $13B.

Commercial Services Miscellaneous Commercial Services stock Stage 2 · Advancing Base 3+
$273.00 latest close
Join to Watchlist $CRL Share card
Verdict · setup score 65/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 65, but price closes below stop $291.52 — stand aside until the condition resets.

Review six verdicts Inspect chart
Earnings

Normal technical setup

No sourced report date Event risk is not modelled for this symbol

Deterministic evidence

CRL-1.92%
Broad market · SPY-0.60%
Same completed session window ending 2026-09-10. -1.32 points vs SPY.

Session internals Weak

Rule: closed flat-to-down and in the bottom third of the range. Judged on internals, not on the size of the move.

Vs prior close-1.92% From the open-0.86% Range position25% GapNo gap
QQQ confirmationConfirming (-1.06%) SMH confirmationConfirming (-2.44%)
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $273.00 -1.9% Sep 10 close
52W High $303.30 10.0% below high
Wks Since High 1w
Base Depth 10.3%
RS Rank 90 percentile of scan
SMA 50 $257.91
Avg Vol 882,616
Rel Vol (Sep 10) 0.87×
More stats
52W Low $144.26
Tight Wks 0
Base B3
SMA 200 $201.88
RS Line vs High -7.9%
RS Line Slope -0.4% ▼
Group Rank #36/58
ADR% 3.0%
ATR(14) $8.05 (3.0%)
Vol Pace (live) N/A
U/D Vol 0.99
A/D Days 21A / 10D
A/D Rating A+
VDU Bars 0/10 d
Position in 52-week range 81stpercentile of the 52-week range
$144.26low
$303.30high

CRL Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for CRL.

Create Free Account

Technical Analysis Report Card

$CRL · $273.00 · as of 2026-09-10 · multi-factor read
80
/ 100
Technicals 80/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$257.91 ↑
100-day$218.24 ↑
200-day$201.88 ↑
Bullish (50 > 200)

RSI (14)

Reading47.0 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateWeakening
Histogram-4.402

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width-1% · 10.3%
Squeeze — volatility compressing

Piercing the lower band — capitulation or strong selling. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol0.99 · Neutral
Rel volume0.87×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $303.3052-week high
Price · $273.00now
S · $218.38swing level
S · $213.40swing level
S · $178.92swing level

Fibonacci · Uptrend swing

23.6%$266.22
38.2%$243.29
50.0%$224.75
61.8%$206.21
78.6%$179.82

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for CRL — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Weekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishRS 92 (leader)
Want this read in a legend's voice? Ask a Legend about CRL
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 6 of 6 legends are Watching — building, not yet a confirmed buy.
Minervini
Watch
Minervini B

Trend-template read: 10/12 pass; wait for the soft misses to improve.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $273.00, MA150 $201.88, MA200 $201.88
1.2 150-day MA > 200-day MAMA150 $201.88 vs MA200 $201.88
Failing evidence
2. ROE ≥ 17%ROE -7.7%
2. Revenue growth ≥ 20% YoY-0.9% YoY
10/12 checks
Method → Playbook → Ask →
O'Neil
Watch
O'Neil D

CANSLIM read: 4/8 pass; improvement is still needed.

Passing evidence
C: Quarterly EPS acceleration ≥ 25%+46.6% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 92
Failing evidence
A: Annual earnings & revenue qualityRev -0.9% | ROE -7.7%
S: Volume ≥ 40% above average on breakoutVolume ratio 0.87x
4/8 checks
Method → Playbook → Ask →
Weinstein
Watch
Weinstein B

Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $273.00 vs MA200 $201.88
Failing evidence
Volume expansion above averageVolume ratio 0.87x
6/7 checks
Method → Playbook → Ask →
Livermore
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$273.00
Relative strengthRS 92
Failing evidence
Volume vs average0.87x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Method → Playbook → Ask →
Darvas
Watch
Darvas B

Box-theory read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$273.00
Relative strengthRS 92
Failing evidence
Volume vs average0.87x
Box top broken on heavy volumeNot confirmed
4/6 checks
Method → Playbook → Ask →
Wyckoff
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$273.00
Relative strengthRS 92
Failing evidence
Volume vs average0.87x
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
4/6 checks
Method → Playbook → Ask →
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Unlock Base & Breakout Tracking
RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling
153RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +6 A+
A: 18 D: 12 Net: +665 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 5/7 met
B 5/7 criteria
Separate score from the Minervini Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✓ EPS acceleration ≥25% QoQ +47%
✗ Revenue growth ≥20% YoY -1%
✓ Gross margin ≥30% 35%
✗ ROE ≥17% -8%
✓ RS rating ≥80 (leadership) 92
✓ Stage 2 uptrend (Weinstein) Stage 2
✓ Within 25% of 52W high -10.0%

Method Playbook

Trade it like Weinstein EXACT LEVELS · PRO
Weinstein B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use Stage 1 resistance and the rising 30-week moving average as the Stage 2 transition boundary.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a Stage 2 breakout above resistance on expanding volume; avoid entries while the 30-week average is flat or falling.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the breakout structure or Stage 1 support where a return to the base invalidates the Stage 2 transition.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Trail beneath rising 30-week support or later higher swing lows while Stage 2 remains intact.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a decisive 30-week support failure or a Stage 3/Stage 4 transition; never treat a failed Stage 2 break as healthy consolidation.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

Momentum Flag ⚠ Late-stage base (#4) ⚠ Negative earnings (CANSLIM C fail)
65 setup score
RS Score 92
Trend template 8/8 ✓
CANSLIM 65.7* (B)
Why This Setup?
Momentum Flag · schematic

prior_advance=43.2%, base_depth=6.3%, contractions=1, tightening=waived (depth<10%), vol_dry=yes, stage2=yes, near_pivot=no | Strong trend (8/8) | Top RS (92) | High-confidence pattern (90%) | Stage 2 | Readiness 70/100 (watch) | CANSLIM 65.7 (B) | ⚠ Late-stage base (#4); Negative earnings (CANSLIM C fail)

Ask a Legend ▾
The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

2/7 universals met
  • Risk is defined — not met No stop — undefined risk
  • Asymmetric reward — partly met No target set
  • Clear of earnings — partly met Report date unknown
  • Not chasing (in range) — partly met Pivot distance unknown
  • Volume confirms — partly met 0.9× average — light
  • A relative-strength leader — met RS rank 90
  • In a confirmed uptrend — met Stage 2 · Trend template 8/8
Why these seven? → The Universal Edge

Minervini Trend Template

8/8 ✓

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $273.00 vs SMA150 $201.88 / SMA200 $201.88
SMA 150 above SMA 200 SMA150 $201.88 vs SMA200 $201.88
SMA 200 trending up Slope +11.38 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $257.91
Price above SMA 50 $273.00 vs SMA50 $257.91
30%+ above 52-week low +89.2% from $144.26
Within 25% of 52-week high -10.0% from $303.30
RS score above 70 RS 92

Fundamentals

52W Range
81%
Mkt Cap SEC
13.0B
EPS QoQ
+47%
Rev YoY
-1%
ROE
-8%
Gross Margin
35%
D/E
0.68
EPS TTM
$-2.91
Float
48M

Company

Company profile
Charles River Laboratories International, Inc.
CRL · NYSE · Commercial Services · Miscellaneous Commercial Services
Track all markets on TradingView
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 65.7* CANSLIM * disqualified on C, M
C · Curr. EPS
40
A · Annual EPS
49
N · New Highs
100
S · Supply/Demand
70
L · Leader RS
92
I · Inst. Spons.
56
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
7/8
W. RS
100
W. Support
$146.20
W. Resist
$303.30
Weekly Structure

Scan History

20× streak
Sep 09: 55 (Three Weeks Tight)Sep 10: 65 (Momentum Flag)Sep 11: 55 (Momentum Flag)Sep 11: 65 (Momentum Flag)65
Sep 11
Momentum Flag ✓ Gate
65
Sep 11
Momentum Flag ✓ Gate
55
Sep 10
Momentum Flag ✓ Gate
65 0.0%
Sep 09
Three Weeks Tight ✓ Gate
55 -1.9%

Get the full picture on CRL

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial